Navigation Links
Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders
Date:11/23/2009

CARLSBAD, Calif., Nov. 23 /PRNewswire-FirstCall/ --

Dear Isis Supporters and Shareholders,

I would like to start by thanking you for your continuing support of Isis. We believe we are at one of the most successful moments in our history. We are truly at the end of the beginning of creating a unique company with a novel drug discovery platform, which we believe addresses many of the issues haunting the pharmaceutical industry.

Our progress is predicated largely upon the success of our flagship drug, mipomersen. Mipomersen continues to perform well and progress toward commercialization. Isis, our investigators and members of the medical community are very encouraged by the results that were presented at the AHA last week. To get a sense of their support of the drug, I would encourage you to listen to the replay of the mipomersen investigator panel presentation that was conducted during AHA last week. I think you will hear not only their enthusiasm for the drug but their hope that mipomersen will provide a new treatment alternative for their patients at very high risk of cardiovascular disease.

We are disappointed with the reaction on Wall Street to what we believe is very positive news. We believe mipomersen will continue to provide results that speak for themselves. Each success brings us closer to getting mipomersen to the market and making the drug available to patients in need.

Our antisense technology provides a direct route from genes to drugs with the opportunity to dramatically improve the productivity of the pharmaceutical industry. With 19 drugs in development, we have one of the largest and most diverse pipelines in our industry. We know that sick people depend on us. We continue to strive for excellence as we create drugs for the future. We also recognize that behind our successes is the support we receive from you. I would like to personally thank you for that.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer
2. Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference
3. Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
4. Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
5. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
6. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
7. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
8. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
9. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
10. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
11. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... For the coming special Friday, Tidebuy, ... a great promotion for many products, especially the beautiful ... the best choice with amazing discounts, up to 90% ... , It is easy to buy colored wedding dresses ... selection is also famous for delicate craftsmanship, elegant style ...
(Date:11/23/2014)... Tbdress.com has recently announced that its Special Friday Shoes ... special offer will provide ladies many gorgeous shoes at greatly ... largest women’s dresses retailers, and its shoes include many models ... on that day: Everything at Tbdress.com is up to 90% ... , People can use the following coupon codes as well: ...
(Date:11/23/2014)... November 23, 2014 Nearly 260 ... attacks, strokes, deep vein thrombosis and other serious ... federal multidistrict litigation (MDL) underway in the Northern ... , Court documents updated on November 17th by ... show the filing of 259 lawsuits against the ...
(Date:11/23/2014)... The holidays can be a challenge for families of ... meltdowns, an expert says. "Holidays with family can ... you have children with special needs, some care must ... University of the Sciences in Philadelphia, said in a ... hosts or visitors know what special requirements are needed ...
(Date:11/23/2014)... 23, 2014 This evaluation provides ... its significance, programs and manufacturing technological innovation. Then, ... major market gamers in information. In this part, ... prospective, manufacturing value, and 2009-2014 market shares for ... symbolizes the globally and Chinese suppliers finish market ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
... ... Officers in MedeFile System During National ... Police Week, CEDAR ... specializing in,portable electronic medical records management solutions, today announced,that in collaboration with the ...
... -- Research findings and innovative approaches offer the promise ... adults living with type 1 diabetes, according to researchers ... Forum in Washington D.C. , Type 1 diabetes is ... insulin-producing beta cells in the pancreas. It renders ...
... A CI head once noted that,"Competitive Intelligence is like ... you realize you need it is when it is ... companies need competitive,intelligence to effectively deal with a turbulent ... that people begin to realize how,critical competitive intelligence is ...
... 18 Sunrise Senior Living,Inc. (NYSE: SRZ ), ... will present at the 2008 Jefferies 2nd Annual,Healthcare Conference ... 1:30 p.m.,Eastern Time. Sunrise will Web cast the presentation ... http://www.sunriseseniorliving.com ). A replay of the Web cast will ...
... Nursing Facility,Funding Cut, COLUMBUS, Ohio, June 18 ... American Health Care Association (AHCA) today,praised Ohio Congressman ... the growing bipartisan effort in Congress to prevent,the ... to,seniors, Medicare Part A nursing home funding - ...
... Inc.,(Nasdaq: HOLX ) today announced that Glenn Muir, ... Annual Healthcare Conference being,held June 24 - 26, 2008, ... Interested parties are invited to listen to a ... 25, 2008, at 12:30 PM.,Eastern Time on the investor ...
Cached Medicine News:Health News:MedeFile International Teams with Newark Fraternal Order of Police 2Health News:MedeFile International Teams with Newark Fraternal Order of Police 3Health News:MedeFile International Teams with Newark Fraternal Order of Police 4Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 2Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 3Health News:Build and Maintain an Effective Competitive Intelligence Group 2Health News:Boehner Thanked for Opposing Funding Cut to Medicare Beneficiaries 2Health News:Hologic to Present at the Jefferies 2nd Annual Healthcare Conference 2
(Date:11/22/2014)... , Nov. 21, 2014  CytoSorbents Corporation ... its European Union approved CytoSorb® cytokine adsorber to ... awarded the Beacon of Light Award at last ... Dr. Phillip Chan , ... an honor to be recognized by the New ...
(Date:11/22/2014)... , Nov. 21, 2014   Long Beach dentist ... are often called the gold standard in tooth replacement because ... a stable, long-lasting way to restore and preserve smiles and ... to replace a missing tooth or as a part of ... the look and feel of a smile. The ...
(Date:11/22/2014)... Fla. , Nov. 21, 2014 MEDITE Group ... reported nine months and the 3 rd quarter sales ... Operating income was $448,000 for the nine months ended September ... 2014. "Even though our 3 rd quarter is usually ... which extends from July into September for many countries worldwide, ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3
... , , , , IRVINE, Calif., Dec. ... Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today ... Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel ... Pacific Time. A live audiocast of the presentation will be ...
... , , , , , ... speciality pharmaceutical,company focused on the discovery and development of ... microbial drug,resistance, announces today that its shareholders have signed ... for a total cash,consideration of up to $505 million, ...
Cached Medicine Technology:Masimo to Present at the 28th Annual J.P. Morgan Healthcare Conference 2Masimo to Present at the 28th Annual J.P. Morgan Healthcare Conference 3Novexel to be Acquired by AstraZeneca 2Novexel to be Acquired by AstraZeneca 3Novexel to be Acquired by AstraZeneca 4
... Clinical Xpert™ for PDAs is a new ... Clinical Xpert puts authoritative drug, disease and ... physicians and other prescribers, nurses, pharmacists, and ... decisions at the point of care, and ...
The 3-chip MediLive Trio Eye video camera is built to adapt to changing conditions during ophthalmic surgery with features designed for workflow optimization and maximum image quality....
... A valuable new tool for ... exhibits greater dynamic range and shows ... SWAP, at the same degree of ... has been shown to correlate with ...
... The VISUCAM non-mydriatic ... quality and simplicity of ... big enough to set ... photography, it features a ...
Medicine Products: